Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
O'Connor
Alec Brian
AB
D000928:Antidepressive Agents / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D003929:Diabetic Neuropathies / Q000150:complications* / Q000191:economics; D016527:Drug Costs; D000068736:Duloxetine Hydrochloride; D006801:Humans; D010146:Pain / Q000188:drug therapy* / Q000191:economics / Q000209:etiology*; D013876:Thiophenes / Q000191:economics / Q000627:therapeutic use*
D000928:Antidepressive Agents; D013876:Thiophenes; D000068736:Duloxetine Hydrochloride